Deutsche Bank AG purchased a new stake in shares of Ventas, Inc. (NYSE:VTR – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 5,088,082 shares of the real estate investment trust’s stock, valued at approximately $451,822,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Capital World Investors bought a new stake in Ventas during the fourth quarter worth approximately $594,116,000. Norges Bank bought a new stake in shares of Ventas during the fourth quarter worth $474,571,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Ventas by 32,509.3% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 4,648,776 shares of the real estate investment trust’s stock valued at $359,722,000 after buying an additional 4,634,520 shares in the last quarter. Cohen & Steers Inc. boosted its holdings in shares of Ventas by 228.1% in the fourth quarter. Cohen & Steers Inc. now owns 4,606,355 shares of the real estate investment trust’s stock valued at $356,440,000 after purchasing an additional 3,202,323 shares during the period. Finally, Daiwa Securities Group Inc. lifted its holdings in shares of Ventas by 188.7% in the 4th quarter. Daiwa Securities Group Inc. now owns 4,705,591 shares of the real estate investment trust’s stock worth $364,119,000 after buying an additional 3,075,450 shares during the period. 94.18% of the stock is owned by hedge funds and other institutional investors.
Ventas Stock Performance
NYSE:VTR opened at $91.18 on Tuesday. The stock has a market capitalization of $46.77 billion, a PE ratio of 168.85, a P/E/G ratio of 2.11 and a beta of 0.69. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The company has a fifty day moving average of $90.68 and a two-hundred day moving average of $86.72. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44.
Insiders Place Their Bets
In other Ventas news, Director Michael J. Embler purchased 2,500 shares of the stock in a transaction that occurred on Wednesday, June 3rd. The shares were purchased at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the completion of the transaction, the director owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.53% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on VTR shares. Royal Bank Of Canada increased their price objective on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a research note on Friday. Mizuho upped their price objective on shares of Ventas from $98.00 to $104.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Cantor Fitzgerald upped their target price on Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a research report on Friday, July 31st. Evercore reissued an “outperform” rating and set a $95.00 price target on shares of Ventas in a research report on Wednesday, April 29th. Finally, BMO Capital Markets boosted their price objective on Ventas from $105.00 to $107.00 and gave the company an “outperform” rating in a report on Tuesday, August 11th. Fifteen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, Ventas has an average rating of “Moderate Buy” and an average target price of $98.00.
Check Out Our Latest Analysis on Ventas
About Ventas
Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.
Ventas’ business model combines property ownership with active asset management and capital markets activity.
Further Reading
- Five stocks we like better than Ventas
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Want to see what other hedge funds are holding VTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ventas, Inc. (NYSE:VTR – Free Report).
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.
